Clemmons, NC, United States of America

Jianfeng Xu

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2009-2022

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations by Jianfeng Xu: Pioneering Genetic Research

Introduction

Jianfeng Xu, a notable inventor based in Clemmons, North Carolina, holds a significant portfolio of 8 patents. His innovative work primarily focuses on the assessment of genetic markers associated with prostate cancer risk, contributing vital advancements in cancer research and screening methodologies.

Latest Patents

Jianfeng Xu’s latest invention revolves around methods and compositions for correlating genetic markers with prostate cancer risk. This groundbreaking approach involves analyzing nucleic acid samples from individuals to determine their genotypes at various biallelic polymorphic loci. By calculating a cumulative relative risk (CRR) based on the determined genotype, the method identifies individuals at an increased risk of developing prostate cancer. A CRR greater than 1.00 indicates a higher risk, categorizing subjects suitable for early PSA screening, prostate biopsies, or chemoprevention, ultimately enhancing patient care and preventive strategies in oncology.

Career Highlights

Throughout his career, Jianfeng Xu has contributed his expertise to reputable institutions, including Wake Forest University and The Johns Hopkins University. His affiliations with these esteemed organizations underscore his commitment to advancing medical research and developing innovative healthcare solutions.

Collaborations

Jianfeng Xu has worked alongside talented colleagues such as Siqun Lilly Zheng and Jielin Sun, fostering a collaborative environment that encourages knowledge sharing and drives the development of pioneering research projects. These partnerships have been instrumental in the successful advancement of his inventions and their applications in clinical settings.

Conclusion

Jianfeng Xu’s innovative contributions to the field of genetic research demonstrate his dedication to improving cancer risk assessment methods. Through his patents, he not only advances scientific knowledge but also enhances the potential for early detection and preventive treatment of prostate cancer, positively impacting the lives of many.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…